FDAClass IIJuly 9, 2025

KETAmine Hydrochloride Injection recall: Sterility Concern

KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only…

Why was KETAmine Hydrochloride Injection recalled?

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 2502009, Exp. 3/2/2026

Product
KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only…
Recalling firm
Tailstorm Health INC
Quantity
14,725 vials
Distribution
Nationwide in the US
Recall date
July 9, 2025
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls